Public Listings for Caprelsa

By | 2018-09-18T23:32:14+00:00 September 18th, 2018|Treatment News|

Caprelsa (vandetanib) is indicated for the treatment of symptomatic or progressive Medullary thyroid cancer in adult patients with unresectable locally advanced or metastatic disease. Alberta Health Services has put the [...]